Free Trial

Exagen (XGN) SEC Filings & 10K Form

Exagen logo
$5.85 +0.13 (+2.27%)
As of 04:00 PM Eastern

Recent Exagen SEC Filings

DateFilerForm TypeView
03/11/2025
8:21 AM
Exagen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
5:48 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:58 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4/A
02/25/2025
7:59 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:59 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 PM
Exagen (Subject)
NMSIC Co-Investment Fund, L.P. (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:00 PM
Exagen (Subject)
Hunt Holdings Limited Partnership (Filed by)
Form SC 13G/A
11/19/2024
6:24 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
5:32 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:39 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
4:08 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:15 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:20 PM
Exagen (Filer)
Form 8-K/A
08/02/2024
7:15 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:02 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
8:27 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
8:30 AM
Exagen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/13/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
8:23 AM
Exagen (Filer)
Form ARS
04/26/2024
7:31 AM
Exagen (Filer)
Exagen (Filer)
Form DEF 14A
04/26/2024
7:32 AM
Exagen (Filer)
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XGN) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners